376 related articles for article (PubMed ID: 18556574)
1. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
2. Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2).
Guendouzi K; Collet X; Perret B; Chap H; Barbaras R
Biochemistry; 1998 Oct; 37(42):14974-80. PubMed ID: 9778375
[TBL] [Abstract][Full Text] [Related]
3. Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I.
Rashid S; Trinh DK; Uffelman KD; Cohn JS; Rader DJ; Lewis GF
Circulation; 2003 Jun; 107(24):3066-72. PubMed ID: 12796142
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.
Rashid S; Watanabe T; Sakaue T; Lewis GF
Clin Biochem; 2003 Sep; 36(6):421-9. PubMed ID: 12951168
[TBL] [Abstract][Full Text] [Related]
5. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
6. Localization and regulation of SR-BI in membrane rafts of HepG2 cells.
Rhainds D; Bourgeois P; Bourret G; Huard K; Falstrault L; Brissette L
J Cell Sci; 2004 Jul; 117(Pt 15):3095-105. PubMed ID: 15226391
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice.
Brundert M; Ewert A; Heeren J; Behrendt B; Ramakrishnan R; Greten H; Merkel M; Rinninger F
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):143-8. PubMed ID: 15528479
[TBL] [Abstract][Full Text] [Related]
8. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
9. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
10. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets.
McCarty MF
Med Hypotheses; 2004; 63(6):1065-73. PubMed ID: 15504577
[TBL] [Abstract][Full Text] [Related]
11. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
12. Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells.
Huard K; Bourgeois P; Rhainds D; Falstrault L; Cohn JS; Brissette L
Int J Biochem Cell Biol; 2005 Jun; 37(6):1308-18. PubMed ID: 15778093
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
14. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models.
Ma K; Forte T; Otvos JD; Chan L
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):149-54. PubMed ID: 15539616
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of lipid metabolism in insulin resistance].
Müller-Wieland D; Krone W
Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
[TBL] [Abstract][Full Text] [Related]
16. Insulin and HDL-cholesterol metabolism.
Fossati P; Romon-Rousseaux M
Diabete Metab; 1987 Jul; 13(3 Pt 2):390-4. PubMed ID: 3308570
[TBL] [Abstract][Full Text] [Related]
17. Lipid and lipoprotein dysregulation in insulin resistant states.
Avramoglu RK; Basciano H; Adeli K
Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
[TBL] [Abstract][Full Text] [Related]
18. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
19. Development of lipoprotein-like lipid particles for drug targeting: neo-high density lipoproteins.
Schouten D; van der Kooij M; Muller J; Pieters MN; Bijsterbosch MK; van Berkel TJ
Mol Pharmacol; 1993 Aug; 44(2):486-92. PubMed ID: 8355672
[TBL] [Abstract][Full Text] [Related]
20. A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein.
Vassiliou G; McPherson R
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1669-75. PubMed ID: 15178567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
